| Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer H Shao, EM Mohamed, GG Xu, M Waters, K Jing, Y Ma, Y Zhang, ... Oncotarget 7 (4), 3832, 2016 | 113 | 2016 |
| Solving a Hamiltonian Path Problem with a bacterial computer J Baumgardner, K Acker, O Adefuye, ST Crowley, W DeLoache, ... Journal of biological engineering 3, 1-11, 2009 | 106 | 2009 |
| Inhibition of injury-induced cell proliferation in the dentate gyrus of the hippocampus impairs spontaneous cognitive recovery after traumatic brain injury D Sun, TE Daniels, A Rolfe, M Waters, R Hamm Journal of neurotrauma 32 (7), 495-505, 2015 | 83 | 2015 |
| Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme JP Newman, GY Wang, K Arima, SP Guan, MR Waters, WK Cavenee, ... Nature communications 8 (1), 1913, 2017 | 73 | 2017 |
| ABCC1-exported sphingosine-1-phosphate, produced by sphingosine kinase 1, shortens survival of mice and patients with breast cancer A Yamada, M Nagahashi, T Aoyagi, WC Huang, S Lima, NC Hait, A Maiti, ... Molecular Cancer Research 16 (6), 1059-1070, 2018 | 63 | 2018 |
| RelB/p50 complexes regulate cytokine-induced YKL-40 expression R Bhardwaj, JW Yester, SK Singh, DD Biswas, MJ Surace, MR Waters, ... The Journal of Immunology 194 (6), 2862-2870, 2015 | 58 | 2015 |
| Long-term sleep disturbance and prescription sleep aid use among cancer survivors in the United States AN Slade, MR Waters, NA Serrano Supportive Care in Cancer 28, 551-560, 2020 | 40 | 2020 |
| RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme MR Waters, AS Gupta, K Mockenhaupt, LSN Brown, DD Biswas, ... Oncogenesis 8 (6), 37, 2019 | 40 | 2019 |
| Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer MA Maczis, M Maceyka, MR Waters, J Newton, M Singh, MF Rigsby, ... Journal of lipid research 59 (12), 2297-2307, 2018 | 32 | 2018 |
| BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands K Mayes, Z Elsayed, A Alhazmi, M Waters, SG Alkhatib, M Roberts, ... Oncotarget 8 (38), 64344, 2017 | 31 | 2017 |
| RelB controls adaptive responses of astrocytes during sterile inflammation AS Gupta, MR Waters, DD Biswas, LN Brown, MJ Surace, C Floros, ... Glia 67 (8), 1449-1461, 2019 | 20 | 2019 |
| Stereotactic body radiation therapy in the treatment of ovarian cancer RO Kowalchuk, MR Waters, KM Richardson, K Spencer, JM Larner, ... Radiation Oncology 15, 1-10, 2020 | 19 | 2020 |
| Sphingosine-1-phosphate inhibits IL-1–induced expression of CC motif ligand 5 via c-Fos–dependent suppression of IFN-β amplification loop JW Yester, L Bryan, MR Waters, B Mierzenski, DD Biswas, AS Gupta, ... The FASEB Journal 29 (12), 4853, 2015 | 17 | 2015 |
| Integrating imaging and RNA-seq improves outcome prediction in cervical cancer J Zhang, R Rashmi, M Inkman, K Jayachandran, F Ruiz, MR Waters, ... The Journal of clinical investigation 131 (5), 2021 | 14 | 2021 |
| STAT3 suppresses Wnt/β-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis MT Cantwell, JS Farrar, JC Lownik, JA Meier, M Hyun, V Raje, MR Waters, ... Cytokine 111, 434-444, 2018 | 14 | 2018 |
| Stereotactic radiosurgery for the treatment of bulky spine metastases RO Kowalchuk, MR Waters, KM Richardson, KM Spencer, JM Larner, ... Journal of Neuro-Oncology 148, 381-388, 2020 | 10 | 2020 |
| Stereotactic body radiation therapy for spinal metastases: a novel local control stratification by spinal region RO Kowalchuk, MR Waters, KM Richardson, K Spencer, JM Larner, ... Journal of Neurosurgery: Spine 34 (2), 267-276, 2020 | 9 | 2020 |
| p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy DV Faget, X Luo, MJ Inkman, Q Ren, X Su, K Ding, MR Waters, GK Raut, ... Cancer Discovery 13 (6), 1454-1477, 2023 | 6 | 2023 |
| Recursive partitioning analysis for local control achieved with stereotactic body radiation therapy for the liver, spine, or lymph nodes RO Kowalchuk, MR Waters, SW Dutta, ML Mack, KM Richardson, ... Advances in Radiation Oncology 6 (3), 100612, 2021 | 6 | 2021 |
| Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer. Oncotarget 2016; 7 (4): 3832-46 H Shao, EM Mohamed, GG Xu, M Waters, K Jing, Y Ma, Y Zhang, ... | 6 | |
